Bank of the Sierra reports record earnings
Sierra Bancorp reported record earnings boosted by lower loan and lease losses and improvements to the overall economy, the bank announced July 19. The parent company of Bank of the Sierra said it had $11.7 million in net income for the quarter ended June 30, or 76 cents per diluted share, compared to $8.3 million Read More →
Limoneira to sell land for new Santa Paula Hospital
The county of Ventura wants to replace Santa Paula Hospital, and it’s working with Limoneira and a third party to make it happen. In a letter of intent released July 14, Limoneira announced it plans to sell 25 acres of its land in Santa Paula to a company called Pacific Coast Investments in five staged Read More →
Teledyne secures Navy contract worth up to $39M
Thousand Oaks-based Teledyne Technologies announced July 19 that its subsidiary, Teledyne Brown Engineering, was awarded a U.S. Navy contract for underwater drones worth as much as $39.2 million. The contract has a maximum base value of $27.4 million over five years, with five one-year option periods and a maximum value of $39.2 million if all Read More →
Cal Poly’s tech incubator heats up with biggest acquisition, expansion plans
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Former MIT Enterprise Forum finds its new identity
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Losses mount at Resonant, but CEO predicts big things as 5G future approaches
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
FDA accuses Amgen of misleading advertising
The U.S. Food and Drug Administration tagged Amgen with a letter July 7 that says the Thousand Oaks biotech firm made “misleading claims” in advertisements for its drug Neulasta, by suggesting it is more effective than biosimilar competitors. Neulasta is a prescription medication used to reduce infection risk from febrile neutropenia (a low level of Read More →
